Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review

Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of medicine 2011-09, Vol.124 (9), p.800-805
Hauptverfasser: Wudhikarn, Kitsada, MD, Perry, Elizabeth H., MD, Kemperman, Melissa, MPH, Jensen, Kathy A., MT(SSB), Kline, Susan E., MD, MPH
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 805
container_issue 9
container_start_page 800
container_title The American journal of medicine
container_volume 124
creator Wudhikarn, Kitsada, MD
Perry, Elizabeth H., MD
Kemperman, Melissa, MPH
Jensen, Kathy A., MT(SSB)
Kline, Susan E., MD, MPH
description Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.
doi_str_mv 10.1016/j.amjmed.2011.03.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_893267867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002934311002476</els_id><sourcerecordid>884846165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</originalsourceid><addsrcrecordid>eNqFkstq3TAQhkVpaU7TvkEpplCysqu77S4K6aGXQCChTXcFIctjkOvLiSQ35O075pwkkE0WQiPp0-if-UXIW0YLRpn-2Bd27EdoC04ZK6goKK2fkQ1TSuUl0_w52VBKeV4LKY7Iqxh7XNJa6ZfkiDNdCcHlhvy5CnaK3RL9POVpjUefErTZF9sAbkYfMz9ldsrOxnGZZjePuzCPPiJyaZOHKX3KTrOtjZD9hN0cErIthv883LwmLzo7RHhzmI_J729fr7Y_8vOL72fb0_PcqZKlXKIW5nCgPmUbLpQD4axqVKm0xu1a11QK0BTACahEJ22nuHNdo7hUTByTk31elHa9QEwGBToYBjvBvERT1YLrstLl02QlK6mZVki-f0T28xImLGNNV3Gl6hWSe8iFOcYAndkFP9pwaxg1q0umN3uXzOqSocKgBXjt3SH30qxnd5fubEHgwwGw0dmhQ1-cjw-cxJYxunKf9xxgd7HjwUSHljhofQCXTDv7p5Q8TuAGP3l88y_cQrwvmZnIDTW_1h-1fiiGXnFZavEfM5rExw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>893825595</pqid></control><display><type>article</type><title>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wudhikarn, Kitsada, MD ; Perry, Elizabeth H., MD ; Kemperman, Melissa, MPH ; Jensen, Kathy A., MT(SSB) ; Kline, Susan E., MD, MPH</creator><creatorcontrib>Wudhikarn, Kitsada, MD ; Perry, Elizabeth H., MD ; Kemperman, Melissa, MPH ; Jensen, Kathy A., MT(SSB) ; Kline, Susan E., MD, MPH</creatorcontrib><description>Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2011.03.009</identifier><identifier>PMID: 21683324</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Anemia ; Anti-Bacterial Agents - therapeutic use ; Antimalarials - therapeutic use ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Babesia ; Babesia microti ; Babesiosis - drug therapy ; Babesiosis - immunology ; Babesiosis - transmission ; Biological and medical sciences ; Blood transfusions ; Clindamycin - therapeutic use ; Drug Therapy, Combination ; Female ; General aspects ; Hemovigilance ; Humans ; Immunocompromised Host - immunology ; Immunocompromised hosts ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Internal Medicine ; Leukemia ; Leukemia, Lymphocytic, Chronic, B-Cell - immunology ; Leukemia, Lymphocytic, Chronic, B-Cell - therapy ; Medical sciences ; Middle Aged ; Opportunistic Infections - drug therapy ; Opportunistic Infections - immunology ; Opportunistic Infections - transmission ; Parasites ; Parasitic diseases ; Polymerase chain reaction ; Quinine - therapeutic use ; Respiratory Insufficiency - immunology ; Splenectomy ; Transfusion Reaction ; Transfusion-transmitted babesiosis ; Womens health</subject><ispartof>The American journal of medicine, 2011-09, Vol.124 (9), p.800-805</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Sequoia S.A. Sep 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</citedby><cites>FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjmed.2011.03.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24483104$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21683324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wudhikarn, Kitsada, MD</creatorcontrib><creatorcontrib>Perry, Elizabeth H., MD</creatorcontrib><creatorcontrib>Kemperman, Melissa, MPH</creatorcontrib><creatorcontrib>Jensen, Kathy A., MT(SSB)</creatorcontrib><creatorcontrib>Kline, Susan E., MD, MPH</creatorcontrib><title>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.</description><subject>Anemia</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antimalarials - therapeutic use</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Babesia</subject><subject>Babesia microti</subject><subject>Babesiosis - drug therapy</subject><subject>Babesiosis - immunology</subject><subject>Babesiosis - transmission</subject><subject>Biological and medical sciences</subject><subject>Blood transfusions</subject><subject>Clindamycin - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>General aspects</subject><subject>Hemovigilance</subject><subject>Humans</subject><subject>Immunocompromised Host - immunology</subject><subject>Immunocompromised hosts</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Internal Medicine</subject><subject>Leukemia</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - immunology</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - therapy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Opportunistic Infections - drug therapy</subject><subject>Opportunistic Infections - immunology</subject><subject>Opportunistic Infections - transmission</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Polymerase chain reaction</subject><subject>Quinine - therapeutic use</subject><subject>Respiratory Insufficiency - immunology</subject><subject>Splenectomy</subject><subject>Transfusion Reaction</subject><subject>Transfusion-transmitted babesiosis</subject><subject>Womens health</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkstq3TAQhkVpaU7TvkEpplCysqu77S4K6aGXQCChTXcFIctjkOvLiSQ35O075pwkkE0WQiPp0-if-UXIW0YLRpn-2Bd27EdoC04ZK6goKK2fkQ1TSuUl0_w52VBKeV4LKY7Iqxh7XNJa6ZfkiDNdCcHlhvy5CnaK3RL9POVpjUefErTZF9sAbkYfMz9ldsrOxnGZZjePuzCPPiJyaZOHKX3KTrOtjZD9hN0cErIthv883LwmLzo7RHhzmI_J729fr7Y_8vOL72fb0_PcqZKlXKIW5nCgPmUbLpQD4axqVKm0xu1a11QK0BTACahEJ22nuHNdo7hUTByTk31elHa9QEwGBToYBjvBvERT1YLrstLl02QlK6mZVki-f0T28xImLGNNV3Gl6hWSe8iFOcYAndkFP9pwaxg1q0umN3uXzOqSocKgBXjt3SH30qxnd5fubEHgwwGw0dmhQ1-cjw-cxJYxunKf9xxgd7HjwUSHljhofQCXTDv7p5Q8TuAGP3l88y_cQrwvmZnIDTW_1h-1fiiGXnFZavEfM5rExw</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Wudhikarn, Kitsada, MD</creator><creator>Perry, Elizabeth H., MD</creator><creator>Kemperman, Melissa, MPH</creator><creator>Jensen, Kathy A., MT(SSB)</creator><creator>Kline, Susan E., MD, MPH</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope></search><sort><creationdate>20110901</creationdate><title>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</title><author>Wudhikarn, Kitsada, MD ; Perry, Elizabeth H., MD ; Kemperman, Melissa, MPH ; Jensen, Kathy A., MT(SSB) ; Kline, Susan E., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anemia</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antimalarials - therapeutic use</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Babesia</topic><topic>Babesia microti</topic><topic>Babesiosis - drug therapy</topic><topic>Babesiosis - immunology</topic><topic>Babesiosis - transmission</topic><topic>Biological and medical sciences</topic><topic>Blood transfusions</topic><topic>Clindamycin - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>General aspects</topic><topic>Hemovigilance</topic><topic>Humans</topic><topic>Immunocompromised Host - immunology</topic><topic>Immunocompromised hosts</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Internal Medicine</topic><topic>Leukemia</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - immunology</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - therapy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Opportunistic Infections - drug therapy</topic><topic>Opportunistic Infections - immunology</topic><topic>Opportunistic Infections - transmission</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Polymerase chain reaction</topic><topic>Quinine - therapeutic use</topic><topic>Respiratory Insufficiency - immunology</topic><topic>Splenectomy</topic><topic>Transfusion Reaction</topic><topic>Transfusion-transmitted babesiosis</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wudhikarn, Kitsada, MD</creatorcontrib><creatorcontrib>Perry, Elizabeth H., MD</creatorcontrib><creatorcontrib>Kemperman, Melissa, MPH</creatorcontrib><creatorcontrib>Jensen, Kathy A., MT(SSB)</creatorcontrib><creatorcontrib>Kline, Susan E., MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wudhikarn, Kitsada, MD</au><au>Perry, Elizabeth H., MD</au><au>Kemperman, Melissa, MPH</au><au>Jensen, Kathy A., MT(SSB)</au><au>Kline, Susan E., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>124</volume><issue>9</issue><spage>800</spage><epage>805</epage><pages>800-805</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>21683324</pmid><doi>10.1016/j.amjmed.2011.03.009</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9343
ispartof The American journal of medicine, 2011-09, Vol.124 (9), p.800-805
issn 0002-9343
1555-7162
language eng
recordid cdi_proquest_miscellaneous_893267867
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anemia
Anti-Bacterial Agents - therapeutic use
Antimalarials - therapeutic use
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Babesia
Babesia microti
Babesiosis - drug therapy
Babesiosis - immunology
Babesiosis - transmission
Biological and medical sciences
Blood transfusions
Clindamycin - therapeutic use
Drug Therapy, Combination
Female
General aspects
Hemovigilance
Humans
Immunocompromised Host - immunology
Immunocompromised hosts
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Internal Medicine
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell - immunology
Leukemia, Lymphocytic, Chronic, B-Cell - therapy
Medical sciences
Middle Aged
Opportunistic Infections - drug therapy
Opportunistic Infections - immunology
Opportunistic Infections - transmission
Parasites
Parasitic diseases
Polymerase chain reaction
Quinine - therapeutic use
Respiratory Insufficiency - immunology
Splenectomy
Transfusion Reaction
Transfusion-transmitted babesiosis
Womens health
title Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A45%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfusion-transmitted%20Babesiosis%20in%20an%20Immunocompromised%20Patient:%20A%20Case%20Report%20and%20Review&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Wudhikarn,%20Kitsada,%20MD&rft.date=2011-09-01&rft.volume=124&rft.issue=9&rft.spage=800&rft.epage=805&rft.pages=800-805&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/j.amjmed.2011.03.009&rft_dat=%3Cproquest_cross%3E884846165%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=893825595&rft_id=info:pmid/21683324&rft_els_id=1_s2_0_S0002934311002476&rfr_iscdi=true